Form 4 Gossamer Bio Inc For: 25 September
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Gossamer Bio Inc (GOSS)
Gossamer Bio Inc stock price live, this page displays NASDAQ GOSS stock exchange data. View the GOSS premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Gossamer Bio Inc real time stock price chart below.
What Is the Gossamer Bio Inc Stock Price Today?
The Gossamer Bio Inc stock price today is 10.710.
What Is the Stock Symbol for Gossamer Bio Inc?
The stock symbol for Gossamer Bio Inc is "GOSS."
What Stock Exchange Does Gossamer Bio Inc Trade On?
Gossamer Bio Inc is listed and trades on the NASDAQ stock exchange.
Is Gossamer Bio Inc a Good Stock to Buy?
Determining whether Gossamer Bio Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GOSS quote. (ISIN: US38341P2011)
What Is the Gossamer Bio Inc Stock Price Today?
The Gossamer Bio Inc stock price today is 10.710.
What Is the Stock Symbol for Gossamer Bio Inc?
The stock symbol for Gossamer Bio Inc is "GOSS."
What Stock Exchange Does Gossamer Bio Inc Trade On?
Gossamer Bio Inc is listed and trades on the NASDAQ stock exchange.
Is Gossamer Bio Inc a Good Stock to Buy?
Determining whether Gossamer Bio Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GOSS quote. (ISIN: US38341P2011)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
10.187
11.190
52 wk Range
9.104
309.600
GOSS is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
10.18711.190
52 wk Range
9.104309.600
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
GOSS Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
82.480
Upside
+670.12%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Gossamer Bio stock rises on FDA filing for PAH drug- Investing.com
- Form 4 Gossamer Bio Inc For: 25 September
- Investing.com
- Gossamer Bio stock rises on FDA filing for PAH drug
- Investing.com
Gossamer Bio Inc receives Investment Bank Analyst Rating Update- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
3 Buy
3 Hold
1 Sell
Ratings:
7 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 82.480
(+670.12% Upside)
Gossamer Bio Inc Earnings Call Summary for Q1/2026
- Gossamer Bio Q1 revenue hit $16.96M, beating $4.71M forecast by 260%, but EPS of -$0.20 missed -$0.17 estimate by 17.65%.
- Stock plunged 41.44% after-hours before recovering 12.09% premarket to $0.20, near 52-week low of $0.16 amid high volatility.
- Company implemented 50% workforce reduction and debt restructuring to extend cash runway into Q1 2027 with $99M on hand.
- Management maintains focus on seralutinib NDA submission targeted for September 2026 despite profitability challenges.
- CFO Giraudo highlighted debt restructuring strengthens balance sheet; CEO Gujrathi emphasized strategic cost management for long-term goals.
Last Updated: 2026-05-21, 05:34 p/m
Read Full TranscriptEarnings
Latest Release
Aug 13, 2026
EPS / Forecast
-6.40 / -9.60
Revenue / Forecast
9.24M / 4.28M
Compare GOSS to Peers and Sector
Metrics to compare | GOSS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipGOSSPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.5x | −1.5x | −0.3x | |
PEG Ratio | 0.08 | −0.01 | 0.00 | |
Price/Book | −0.7x | 4.6x | 2.6x | |
Price / LTM Sales | 1.2x | 49.4x | 3.0x | |
Upside (Analyst Target) | - | 79.8% | 58.6% | |
Fair Value Upside | Unlock | 7.2% | 8.4% | Unlock |
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary hypertension and pulmonary arterial hypertension in the United States. The company develops GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony-stimulatin factor 1 receptor and c-KIT inhibitor, which is in Phase 3 clinical trial for the treatment of PAH. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. The company was incorporated in 2015 and is headquartered in San Diego, California.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Gossamer Bio (GOSS) Stock Price Today?
The Gossamer Bio stock price today is 10.710 USD.
What Stock Exchange Does Gossamer Bio Trade On?
Gossamer Bio is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Gossamer Bio?
The stock symbol for Gossamer Bio is "GOSS."
What Is the Gossamer Bio Market Cap?
As of today, Gossamer Bio market cap is 66.790M USD.
What Is Gossamer Bio's Earnings Per Share (TTM)?
The Gossamer Bio EPS (TTM) is -51.969.
When Is the Next Gossamer Bio Earnings Date?
Gossamer Bio will release its next earnings report on Nov 05, 2026.
From a Technical Analysis Perspective, Is GOSS a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Gossamer Bio Stock Split?
Gossamer Bio has split 1 times.
How Many Employees Does Gossamer Bio Have?
Gossamer Bio has 162 employees.
What is the current trading status of Gossamer Bio (GOSS)?
As of Oct 03, 2026, Gossamer Bio (GOSS) is trading at a price of 10.710 USD, with a previous close of 10.710 USD. The stock has fluctuated within a day range of 10.187 USD to 11.190 USD, while its 52-week range spans from 9.104 USD to 309.600 USD.
What Is Gossamer Bio (GOSS) Price Target According to Analysts?
The average 12-month price target for Gossamer Bio is 82.480 USD, with a high estimate of 120 USD and a low estimate of 22.4 USD. 3 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +670.12% Upside potential.
What Is the GOSS Premarket Price?
GOSS's last pre-market stock price is 11.180 USD. The pre-market share volume is 5,160.000, and the stock has decreased by 0.250, or 2.290%.
What Is the GOSS After Hours Price?
GOSS's last after hours stock price is 10.550 USD, the stock has decreased by -0.160, or -1.490%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.